ORIKAN
ORIKAN
Not authorised
- NEOMYCIN SULFATE
- Triamcinolone acetonide
- Nystatin
- Thiostrepton
Product identification
Medicine name:
ORIKAN
Active substance:
- NEOMYCIN SULFATE
- Triamcinolone acetonide
- Nystatin
- Thiostrepton
Target species:
-
Dog
-
Cat
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
NEOMYCIN SULFATE2841.00/international unit(s)1.00gram(s)
-
Triamcinolone acetonide1.13/milligram(s)1.00gram(s)
-
Nystatin113636.00/international unit(s)1.00gram(s)
-
Thiostrepton2841.00/international unit(s)1.00gram(s)
Pharmaceutical form:
-
Ear ointment
Withdrawal period by route of administration:
-
Auricular use
-
Dog
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA04
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
France
Package description:
- Available only in French
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
- Laboratoire Perrigo France
Marketing authorisation date:
Manufacturing sites for batch release:
- Elanco France S.A.S.
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/2025808 5/2012
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 7/04/2022
How useful was this page?:
